| Name | Title | Contact Details |
|---|
Dental Health Alliance is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The mission of Cascadia Behavioral Healthcare is to create hope and opportunity for low income people with mental illnesses and addictions, blending innovation and determination with competence, inclusion and compassion. The heart of Cascadia is our people those we serve, our co-workers, and our community partners. Together we are focused on efficiency, committed to diversity and grounded in compassion.We are consumers, counselors, accountants, case managers, nurses, administrative support workers, doctors, and the full complement of all the people needed to bring results. For many of us this is not just a job, it`s a calling. Our Vision: We envision a future where everyone with a mental illness or addiction will recover and have a full life in the community. Our Mission: Cascadia provides healing, homes, and hope for people living with mental health and addiction challenges. Cascadia brings health and housing services to those who need them most. With 75 sites in Oregon`s Multnomah and Clackamas Counties, we help create a sense of community We`ve learned that families are an important part of people`s lives and offer services unique to children, families, adults and older adults: •Community- and Clinic-Based Mental Health and Addiction Services •Peer Wellness •Urgent and Emergency Services •Homeless Services •Forensics •Medical •Housing Development
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Lakeview Village soon became a leading Continuing Care Retirement Community (CCRC) in the Kansas City metropolitan area, and is now the largest in Kansas.
Alphadetail Inc is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.